Home › Funds › Gem Investment Advisors, LLC › ENTX
Gem Investment Advisors, LLC position in ENTX
ENTERA BIO LTD · Health Care
Gem Investment Advisors, LLC reported holding 19,135 shares of ENTX (ENTERA BIO LTD) in its Q3 2026 13F filing — a position valued at US$56K, representing 0.04% of its reported portfolio and ranking #32 among its reported holdings. Gem Investment Advisors, LLC has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Gem Investment Advisors, LLC's ENTX position evolved
Gem Investment Advisors, LLC first disclosed a stake in ENTX in Q4 2025 at 19,135 shares (US$37K). The position peaked in Q3 2026 at 19,135 shares, worth US$56K. Across 4 filings, Gem Investment Advisors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 19,135 shares valued at US$56K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 19.14K | $37.12K | New |
| Q1 2026 | 19.14K | $21.24K | Hold |
| Q2 2026 | 19.14K | $33.87K | Hold |
| Q3 2026 | 19.14K | $55.68K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENTX and 13F data
ENTX (ENTERA BIO LTD) is a Health Care company. 33 other funds we track also report a position in ENTX — the largest reported positions include Vivo Capital, LLC (US$35.7M), Spruce Street Capital LP (US$32.6M), Knoll Capital Management, LLC (US$10.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENTX
- Vivo Capital, LLC 12.25M sh · $35.66M · Q3 2026
- Spruce Street Capital LP 11.21M sh · $32.63M · Q3 2026
- Knoll Capital Management, LLC 5.88M sh · $10.41M · Q2 2026
- NEXTBio Capital Management LP 2.92M sh · $8.51M · Q3 2026
- BVF INC/IL 2.42M sh · $4.29M · Q2 2026
More on Gem Investment Advisors, LLC
FAQ
How long has Gem Investment Advisors, LLC held ENTX?
Gem Investment Advisors, LLC has disclosed ENTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Gem Investment Advisors, LLC's current position in ENTX?
As of Q3 2026, Gem Investment Advisors, LLC holds 19.14K shares of ENTX (ENTERA BIO LTD), valued at $55.68K, representing 0.04% of its reported portfolio and ranking #32.
Has Gem Investment Advisors, LLC been buying or selling ENTX?
In the latest 13F filing (Q3 2026), Gem Investment Advisors, LLC held unchanged its position in ENTX. The position peaked in Q3 2026 at 19.14K shares.
Which other funds hold ENTX?
Other major institutional holders of ENTX include Vivo Capital, LLC, Spruce Street Capital LP, Knoll Capital Management, LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.